SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-007977
Filing Date
2016-08-15
Accepted
2016-08-15 07:33:41
Documents
59
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mirn-20160630x10q.htm 10-Q 1667299
2 EX-10.1 mirn-20160630ex1017afb72.htm EX-10.1 870778
3 EX-10.2 mirn-20160630ex1023e40c3.htm EX-10.2 89059
4 EX-10.3 mirn-20160630ex103e8521c.htm EX-10.3 162825
5 EX-31.1 mirn-20160630ex311106ce1.htm EX-31.1 18940
6 EX-31.2 mirn-20160630ex3129a0c01.htm EX-31.2 18446
7 EX-32.1 mirn-20160630ex3213a3f5c.htm EX-32.1 12302
8 GRAPHIC mirn20160630ex1017afb72001.jpg GRAPHIC 14832
9 GRAPHIC mirn20160630ex1017afb72002.jpg GRAPHIC 37413
  Complete submission text file 0001558370-16-007977.txt   6262069

Data Files

Seq Description Document Type Size
10 EX-101.INS mirn-20160630.xml EX-101.INS 961814
11 EX-101.SCH mirn-20160630.xsd EX-101.SCH 33246
12 EX-101.CAL mirn-20160630_cal.xml EX-101.CAL 35702
13 EX-101.DEF mirn-20160630_def.xml EX-101.DEF 111998
14 EX-101.LAB mirn-20160630_lab.xml EX-101.LAB 318894
15 EX-101.PRE mirn-20160630_pre.xml EX-101.PRE 219342
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744 512-681-5252
Mirna Therapeutics, Inc. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37566 | Film No.: 161830034
SIC: 2834 Pharmaceutical Preparations